During the past decade, The Parkinson's and Movement Disorder Institute conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 13 clinical trials were completed, i.e. on average, 59.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Parkinson's and Movement Disorder Institute" #1 sponsor was "Ipsen" with 6 trials, followed by "Revance Therapeutics, Inc." with 4 trials sponsored, "Sunovion" with 3 trials sponsored, "AEON Biopharma, Inc." with 2 trials sponsored and "Chelsea Therapeutics" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Parkinson's and Movement Disorder Institute" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "The Parkinson Study Group" with 3 trials as a collaborator, "H. Lundbeck A/S" with 2 trials as a collaborator, "Michael J. Fox Foundation for Parkinson's Research" with 2 trials as a collaborator and "National Institute on Aging (NIA)" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "The Parkinson's and Movement Disorder Institute" are "Cervical Dystonia" (9 trials), "Parkinson Disease" (8 trials), "Parkinson's Disease" (7 trials), "Dementia With Lewy Bodies" (3 trials) and "Multiple System Atrophy" (3 trials). Many other conditions were trialed in "The Parkinson's and Movement Disorder Institute" in a lesser frequency.

Most popular intervention types in "The Parkinson's and Movement Disorder Institute" are "Drug" (27 trials), "Biological" (9 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Botulinum toxin type A" (5 trials), "APL-130277" (3 trials), "ABP-450" (2 trials) and "Active Investigational Treatment ENT-01" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Parkinson's and Movement Disorder Institute" are 38 trials for "All" genders.

Currently, there are NaN active trials in "The Parkinson's and Movement Disorder Institute". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in The Parkinson's and Movement Disorder Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Parkinson's and Movement Disorder Institute, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".